The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients

[1]  B. Agnarsson,et al.  The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714predict adverse outcome for breast cancer patients , 2012, BMC Cancer.

[2]  Jaana M. Hartikainen,et al.  The role of genetic breast cancer susceptibility variants as prognostic factors. , 2012, Human molecular genetics.

[3]  Swneke D. Bailey,et al.  Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression , 2012, Nature Genetics.

[4]  A. Uitterlinden,et al.  Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes , 2012, Breast Cancer Research and Treatment.

[5]  K. Matsuo,et al.  A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population , 2012, Breast Cancer Research and Treatment.

[6]  A. Ashworth,et al.  Genetic Variants at Chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 Influence the Risk of Breast Cancer in Men , 2011, PLoS genetics.

[7]  Patrick Neven,et al.  Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. , 2011, Human molecular genetics.

[8]  C. Carty,et al.  Replication of Breast Cancer GWAS Susceptibility Loci in the Women's Health Initiative African American SHARe Study , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[9]  Wonshik Han,et al.  Common Genetic Variants Associated with Breast Cancer in Korean Women and Differential Susceptibility According to Intrinsic Subtype , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[10]  W. Shen,et al.  Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects , 2011, Breast Cancer Research and Treatment.

[11]  Gabriella Siszler,et al.  TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex , 2011, Journal of Cell Science.

[12]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[13]  Mads Thomassen,et al.  Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. , 2010, Cancer research.

[14]  J. Long,et al.  Evaluation of Breast Cancer Susceptibility Loci in Chinese Women , 2010, Cancer Epidemiology, Biomarkers and Prevention.

[15]  V. Beral,et al.  Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. , 2010, JAMA.

[16]  M. Ringnér,et al.  Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics , 2010, Breast Cancer Research.

[17]  Carlos Caldas,et al.  Fine scale mapping of the breast cancer 16q12 locus. , 2010, Human molecular genetics.

[18]  T. Meitinger,et al.  Low‐risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients , 2010, International journal of cancer.

[19]  Deborah Hughes,et al.  Genome-wide association study identifies five new breast cancer susceptibility loci , 2010, Nature Genetics.

[20]  Montserrat Garcia-Closas,et al.  Genetic susceptibility to breast cancer , 2010, Molecular oncology.

[21]  J. Palmer,et al.  Polymorphisms in the TOX3/LOC643714 Locus and Risk of Breast Cancer in African-American Women , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[22]  Hongbing Shen,et al.  Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population , 2010, Breast Cancer Research and Treatment.

[23]  J. Long,et al.  Evaluation of 11 Breast Cancer Susceptibility Loci in African-American Women , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[24]  N. Miller,et al.  Low penetrance breast cancer predisposition SNPs are site specific , 2009, Breast Cancer Research and Treatment.

[25]  Anirvan Ghosh,et al.  Tox3 Regulates Calcium-dependent Transcription in Neurons We Report the Cloning and Characterization of Tox3, a High Mobility Group Box Protein Involved in Mediating Calcium-dependent Tran- Scription. Tox3 Was Identified as a Calcium-dependent Transactivator Using the Transactivator Trap Screen. We , 2022 .

[26]  Nazneen Rahman,et al.  Genetic predisposition to breast cancer: past, present, and future. , 2008, Annual review of genomics and human genetics.

[27]  Dieter Niederacher,et al.  Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2008, American journal of human genetics.

[28]  Peter Kraft,et al.  Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics , 2008, PLoS genetics.

[29]  C. Pipper,et al.  [''R"--project for statistical computing]. , 2008, Ugeskrift for laeger.

[30]  A. Børresen-Dale,et al.  Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes , 2007, Breast Cancer Research.

[31]  J. Klijn,et al.  Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases , 2007, Breast Cancer Research.

[32]  Charles M Perou,et al.  FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival , 2007, Clinical Cancer Research.

[33]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[34]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[35]  Yi Zhang,et al.  Genes associated with breast cancer metastatic to bone. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.

[37]  Joel Greshock,et al.  High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization , 2005, Breast Cancer Research.

[38]  J. Kaye,et al.  TOX defines a conserved subfamily of HMG-box proteins , 2003, BMC Genomics.

[39]  J. Hur,et al.  Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. , 2001, Genes & development.

[40]  K. Isselbacher,et al.  Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. McInnis,et al.  cDNAs with long CAG trinucleotide repeats from human brain , 1997, Human Genetics.

[42]  A. Giordano,et al.  Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. , 1993, Oncogene.

[43]  D. Lipman,et al.  National Center for Biotechnology Information , 2019, Springer Reference Medizin.

[44]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[45]  Ncbi.  National Center for Biotechnology Information , 2008 .

[46]  Nazneen Rahman,et al.  The emerging landscape of breast cancer susceptibility , 2007, Nature Genetics.

[47]  Leila Mohammadi,et al.  BMC Cancer , 2001 .